Table 1 Demographic and clinical characteristics of all participants.

From: Associations between four insulin resistance (IR) surrogates and the risk of small cell lung cancer (SCLC)

 

Controls (n = 235)

SCLC (n = 235)

P value

Age (years)

65(59–71)

65(59–71)

1

Sex (Male/Female)

55/180

55/180

1

Smoking (%)

48(20.4%)

145(61.7%)

 < 0.001

Hypertension (%)

46(19.6%)

102(43.4%)

 < 0.001

BMI (kg/m2)

24.28 ± 3.15

24.86 ± 3.44

0.06

WBCC (× 10^9/L)

5.51(4.72–6.83)

6.63(5.49–8.09)

 < 0.001

Neutrophil count (× 10^9/L)

3.72(2.91–4.80)

4.54(3.51–5.82)

 < 0.001

FBG (mmol/L)

5.07 ± 0.67

5.36 ± 1.17

0.001

TC (mmol/L)

4.63 ± 0.78

4.61 ± 0.95

0.805

TG (mmol/L)

0.82 ± 0.21

1.18 ± 0.57

 < 0.001

LDL-C(mmol/L)

2.88 ± 0.60

2.99 ± 0.72

0.084

HDL-C(mmol/L)

1.28(1.13–1.54)

1.14(0.96–1.36)

 < 0.001

Uric acid (umol/l)

293.56 ± 78.32

277.40 ± 101.96

0.055

TyG index

8.06 ± 0.31

8.42 ± 0.48

 < 0.001

TyG-BMI

195.98 ± 28.27

209.81 ± 34.23

 < 0.001

TG/HDL-C

1.47 ± 0.51

2.49 ± 1.55

 < 0.001

METS-IR

34.44 ± 5.54

37.47 ± 6.44

 < 0.001

  1. BMI, body mass index; WBCC, white blood cell count; FBG, fasting blood glucose; TC, total cholesterol; TG, triacylglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TyG index, triglyceride‒glucose index; TyG-BMI, TyG index with body mass index; TG/HDL-C, triglyceride/high-density lipoprotein cholesterol ratio; METS-IR, metabolic score for insulin resistance.